Wednesday, January 27, 2021
Home Life Style Health & Fitness Risk and Disease Severity to Be Considered During COVID Vaccine Distribution

Risk and Disease Severity to Be Considered During COVID Vaccine Distribution

The Factors Affecting the Risk of Dispensing COVID Vaccine

The government would look at two key considerations for prioritization of the COVID-19 vaccine — the occupational hazard and risk of exposure to infection, and secondly, the risk of developing severe disease and increased mortality, Union Health Minister Harsh Vardhan said on Sunday.

Besides, the supply of vaccines is anticipated to be available in limited quantities in the beginning, he added, during ‘Sunday Samvaad’, a weekly webinar which he hosts every Sunday for his social media audience.

“In a huge country like India, it is critical to prioritize vaccine delivery based on various factors such as per risk of exposure, co-morbidity among various population groups, the mortality rate among COVID cases, and several others,” he said while adding that India is looking at the availability of several different types of vaccines.

Follow NewsGram on Facebook to stay updated.

On the issue of emergency authorization of COVID vaccines in India, the Minister said that the issue is being deliberated at present.

“Adequate safety and efficacy data are required for emergency use authorization of vaccine for ensuring patient safety. Further course of action will depend on the data generated,” he added.

COVID Vaccine
The third vaccine candidate under human trial is ZyCoV-D, developed by Zydus Cadila. This candidate is now under Phase-1 and Phase-2 of clinical trials. Unsplash

Harsh Vardhan also informed that COVID-19 vaccines currently in trial in India are two and three-dose vaccines.

“Vaccine by the Serum Institute of India and Bharat Biotech require two doses while the Cadila Healthcare vaccine requires three doses. For other vaccines in preclinical stages, the dosing is being tested,” he stated.

Three potential vaccines are being tested in India, including Covishield which was developed jointly by the Jenner Institute of University of Oxford and pharma giant AstraZeneca.

Covishield is in Phase-2 and Phase-3 human trials and, if successful, will be mass-produced by the Pune-based Serum Institute of India (SII), one of the world’s largest manufacturers of vaccines. Its trials in India are running at 17 locations across the country.

Besides, Bharat Biotech, in collaboration with the Indian Council of Medical Research and the National Institute of Virology, is conducting Phase-1 and Phase-2 clinical trials of its vaccine candidate COVAXIN.

COVID Vaccine
The government would look at two key considerations for prioritization of the Covid-19 vaccine — the occupational hazard and risk of exposure to infection, and secondly, the risk of developing severe disease and increased mortality. Unsplash

The third vaccine candidate under human trial is ZyCoV-D, developed by Zydus Cadila. This candidate is now under Phase-1 and Phase-2 of clinical trials.

The World Health Organisation (WHO) had released the ‘Draft landscape of Covid-19 candidate vaccines’, on September 30, where it said that as many as 191 vaccine candidates are in various stages of development across the globe. Among these, 41 candidate vaccines have made their way into clinical trials while ten have entered the third phase of clinical trials.

Also Read: Households Expect Inflation to Remain Elevated Over Next One Year: Survey

Harsh Vardhan also said that the government is open to assess the feasibility of introducing several Covid-19 vaccines in the country as per their availability for the Indian population.

“Considering the large population size of India, one vaccine or vaccine manufacturer will not be able to fulfill the requirements of vaccinating the whole country. Therefore, we are open to assessing the feasibility of introducing several Covid-19 vaccines in the country as per their availability for the Indian population.” (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

High Omega-3 Levels Reduce The Death Risk In Covid

People with higher omega-3 levels in their blood may have a reduced risk of death from Covid-19 infection, a new study suggests. The findings, published...

People Hesitant To Visit The Emergency In USA For Children

Nearly one in four families in the USA had said that they would be unlikely to bring their child to the emergency ward if...

UNEP Says There Is An Increase In Climate Litigations

Climate litigation cases have spiked in recent years, making the courtroom increasingly relevant to efforts to address climate change around the world, an UN...

Study Links Light Pollution And Preterm Birth

Light pollution, based on a direct measure of skyglow, could increase the likelihood of preterm birth, a new study suggests. The study, published in the...

A Farmer Protest Timeline: How Things Turned Violent In Delhi On R-Day

Farmers, who were seen as friendly and peaceful for more than 60 days as they waited for the government to accept their terms, suddenly...

Happy Childhood May Lower Drug Risk Among Teens

If your teenage child has memories of a happy childhood, they are less likely to indulge in drinking or substance abuse and enjoy learning,...

Priyanka Chopra: Its Enlightening To Understand The Importance Of Women In Leadership

Actress Priyanka Chopra Jonas is celebrating the women who helped in drafting the Indian Constitution and says it has been enlightening to understand the...

72nd Republic Day: Time For A Patriotic Musical Rewind

As India celebrates 72nd Republic Day on Tuesday, it is time for a musical rewind of Republic Day songs. There are countless classics that spring...

Recent Comments